Currently out of the existing stock ratings of Craig Wong-Pan, 5 are a SELL (14.29%), 19 are a HOLD (54.29%), 11 are a BUY (31.43%).

Craig Wong-Pan

Work Performance Price Targets & Ratings Chart

Analyst Craig Wong-Pan, currently employed at RBC, has had 77.14% of price targets met with an average potential upside of 22.9%, reached in 279 days on average.

Craig Wong-Pan has documented 70 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on RMD, ResMed at 30-Oct-2026.

Wall Street Analyst Craig Wong-Pan

Analyst best performing recommendations are on RMD (RESMED).
The best stock recommendation documented was for RMD (RESMED) on 4/10/2024. The price target of $187 was fulfilled within 1 day with a profit of $2.24 (1.18%), with a performance score of 11.84.

Average potential price target upside

RMD ResMed

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 13-Oct-2025

$250

$10.47 (4.37%)

$215

20 days ago
(30-Oct-2026)

4/6 (66.67%)

$20.06 (8.72%)

40

Buy Since 06-Feb-2024

$277

$37.47 (15.64%)

$267

20 days ago
(30-Oct-2026)

7/16 (43.75%)

$47.06 (20.47%)

144

Buy Since 30-Oct-2026

$288

$48.47 (20.24%)

$262

20 days ago
(30-Oct-2026)

27/35 (77.14%)

$58.06 (25.25%)

279

Hold Since 30-Oct-2026

$270

$30.47 (12.72%)

$235

20 days ago
(30-Oct-2026)

9/15 (60%)

$40.06 (17.42%)

60

Hold Since 19-Aug-2026

$230

$8 (3.60%)

3 months ago
(19-Aug-2026)

1/1 (100%)

$0.01 (0.00%)

2

Show more analysts

Please expand the browser size to see the chart

Which stock is Craig Wong-Pan most bullish on?

Potential upside of $48.47 has been obtained for RMD (RESMED)

What Year was the first public recommendation made by Craig Wong-Pan?

On 2021
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?